RSS feeds allow Web site content to be gathered via feed reader software. Click the subscribe link to obtain the feed URL for this page. The feed will update when new content appears on this page.

David E.I. Pyott

A collection of news and information related to David E.I. Pyott published by this site and its partners.

Top David E.I. Pyott Articles see all

Displaying items 1-5
  • Office Depot CEO could walk with $39 million after merger

    Office Depot CEO could walk with $39 million after merger
    After less than two years on the job, Office Depot CEO Roland Smith could receive $39 million if the Staples-Office Depot merger is finalized, executive pay experts say.
  • Few Allergan execs to keep top jobs in Actavis takeover

    Few Allergan execs to keep top jobs in Actavis takeover
    The soon-to-be owner of Irvine-based Allergan Inc. announced sweeping leadership changes that pass over many current executives including the Botox maker's CEO. Irish pharmaceutical giant Actavis expects to finalize its $66-billion acquisition in the...

    Allergan sale to Actavis thwarts takeover attempt by Valeant

    Botox maker Allergan Inc., an Irvine company that started as a purveyor of eye drops and grew into one of the most respected pharmaceutical companies in the country, agreed to be acquired by Irish firm Actavis for $66 billion. The deal thwarts a...

    Valeant says it's willing to raise offer for Allergan to $200 a share

    As shareholders of Botox maker Allergan Inc. prepare for a vote on the company's future, a Canadian suitor said it's willing to increase its offer to buy the Irvine firm. J. Michael Pearson, chief executive of Valeant Pharmaceuticals International Inc.,...

    Allergan, embroiled in takeover battle, raises its profit forecast

    Allergan, embroiled in takeover battle, raises its profit forecast
    Botox maker Allergan lifted its profit outlook Thursday as it tries to stave off a takeover attempt from a Canadian rival. The Irvine-based drug maker said it expects to earn between $1.76 and $1.78 a share during the third quarter, up from its previous...